Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.PubMedCrossrefGoogle Scholar
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015;136:178–82.CrossrefPubMedWeb of ScienceGoogle Scholar
Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010;11:1160–71.Web of ScienceCrossrefPubMedGoogle Scholar
Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 2015;21:817–26.Web of SciencePubMedCrossrefGoogle Scholar
Wang X, Liu F, Jiang L, Bao Y, Xiao Y, Wang H. External quality assessment for human papillomavirus 16/18 DNA detection and genotyping in Shanghai, China. Clin Chem Lab Med 2017;55:195–202.Web of ScienceGoogle Scholar
Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, et al. Development and characterization of the cobas human papillomavirus test. J Clin Microbiol 2013;51:1478–84.Web of SciencePubMedCrossrefGoogle Scholar
Robadi IA, Pharaon M, Ducatman BS. The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia. Arch Pathol Lab Med 2018;142:693–5.Web of ScienceCrossrefPubMedGoogle Scholar
About the article
Published Online: 2019-07-08
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was funded by the Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2015–2017) (No. 15GWZK0301) and Shanghai Municipal Commission of Health and Family Planning (No. 201740002).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.